Compare NRP & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRP | TNDM |
|---|---|---|
| Founded | 2002 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2002 | 2013 |
| Metric | NRP | TNDM |
|---|---|---|
| Price | $102.97 | $23.18 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 19 |
| Target Price | N/A | ★ $28.00 |
| AVG Volume (30 Days) | 41.8K | ★ 2.2M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.56% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $216,119,000.00 | ★ $1,014,736,000.00 |
| Revenue This Year | N/A | $8.11 |
| Revenue Next Year | N/A | $11.85 |
| P/E Ratio | $11.28 | ★ N/A |
| Revenue Growth | ★ 54.66 | 7.93 |
| 52 Week Low | $95.51 | $10.25 |
| 52 Week High | $128.60 | $29.65 |
| Indicator | NRP | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 56.20 | 72.67 |
| Support Level | $101.10 | $19.70 |
| Resistance Level | $107.61 | $24.23 |
| Average True Range (ATR) | 2.42 | 1.34 |
| MACD | 0.63 | 0.46 |
| Stochastic Oscillator | 56.46 | 90.75 |
Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. The majority of the revenue is generated from the Mineral Rights segment. Geographically, the company's business activity of the group functions through the United States.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.